| Modulation of the development of human monocyte-derived dendritic cells by lithium chloride. | |
| | |
MedLine Citation:
|
PMID: 20672290 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Lithium has been used or explored to treat psychiatric and neurodegenerative diseases that are frequently associated with an abnormal immune status. It is likely that lithium may work through modulation of immune responses in these patients. Because dendritic cells (DC) play a central role in regulating immune responses, this study investigated the influence of lithium chloride (LiCl) on the development and function of DC. Exposure to LiCl during the differentiation of human monocyte-derived immature DCs (iDC) enhances CD86 and CD83 expression and increases the production of IL-1β, IL-6, IL-8, IL-10, and TNF-α. However, the presence of LiCl during LPS-induced maturation of iDC has the opposite effect. During iDC differentiation, LiCl suppresses the activity of glycogen synthase kinase (GSK)-3β, and activates PI3K and MEK. In addition, LiCl activates peroxisome proliferator-activated receptor γ (PPARγ) during iDC differentiation, a pathway not described before. Each of these signaling pathways appears to have distinct impact on the differentiating iDC. The enhanced CD86 expression by LiCl involves the PI3K/AKT and GSK-3β pathway. LiCl modulates the expression of CD83 in iDC mainly through MEK/ERK, PI3K/AKT, and PPARγ pathways, while the increased production of IL-1β and TNF-α mainly involves the MEK/ERK pathway. The effect of LiCl on IL-6/IL-8/IL-10 secretion in iDC is mediated through inhibition of GSK-3β. We have also demonstrated that PPARγ is downstream of GSK-3β and is responsible for the LiCl-mediated modulation of CD86/83 and CD1 expression, but not IL-6/8/10 secretion. The combined influence of these molecular signaling pathways may account for certain clinical effect of lithium. |
| | |
Authors:
|
Ko-Jiunn Liu; Yueh-Lun Lee; Yi-Yuan Yang; Neng-Yao Shih; Chia-Chen Ho; Yu-Chen Wu; Tze-Sing Huang; Ming-Chyi Huang; Hsing-Cheng Liu; Winston W Shen; Sy-Jye Leu |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of cellular physiology Volume: 226 ISSN: 1097-4652 ISO Abbreviation: J. Cell. Physiol. Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2010-11-30 Completed Date: 2011-01-06 Revised Date: 2011-11-02 |
Medline Journal Info:
|
Nlm Unique ID: 0050222 Medline TA: J Cell Physiol Country: United States |
Other Details:
|
Languages: eng Pagination: 424-33 Citation Subset: IM |
Copyright Information:
|
© 2010 Wiley-Liss, Inc. |
Affiliation:
|
National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adjuvants, Immunologic
/
pharmacology Animals Antigens, CD / immunology Antigens, CD86 / immunology Cell Differentiation / drug effects, immunology Cells, Cultured Dendritic Cells / cytology, drug effects*, physiology* Enzyme Inhibitors / metabolism Glycogen Synthase Kinase 3 / immunology Humans Immunoglobulins / immunology Interleukins / immunology Lithium Chloride / pharmacology* Membrane Glycoproteins / immunology Mitogen-Activated Protein Kinase Kinases / immunology Monocytes / cytology, drug effects*, physiology* PPAR gamma / immunology Phosphatidylinositol 3-Kinases / metabolism Signal Transduction Tumor Necrosis Factor-alpha / immunology |
| Chemical | |
Reg. No./Substance:
|
0/Adjuvants, Immunologic; 0/Antigens, CD; 0/Antigens, CD86; 0/CD83 antigen; 0/Enzyme Inhibitors; 0/Immunoglobulins; 0/Interleukins; 0/Membrane Glycoproteins; 0/PPAR gamma; 0/Tumor Necrosis Factor-alpha; 7447-41-8/Lithium Chloride; EC 2.7.1.-/Phosphatidylinositol 3-Kinases; EC 2.7.11.1/glycogen synthase kinase 3 beta; EC 2.7.11.26/Glycogen Synthase Kinase 3; EC 2.7.12.2/Mitogen-Activated Protein Kinase Kinases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Thrombin promotes actin stress fiber formation in RPE through Rho/ROCK-mediated MLC phosphorylation.
Next Document: Hypovitaminosis D and ethnic differences in insulin resistance.